2025-01-17 CALL at $260.0 Option on Biogen Inc
BIIB Stock | USD 225.43 6.56 2.83% |
2025-01-17 CALL at $260.0 is a CALL option contract on Biogen's common stock with a strick price of 260.0 expiring on 2025-01-17. The contract was last traded on 2024-06-06 at 09:48:36 for $13.41 and, as of today, has 223 days remaining before the expiration. The option is currently trading at a bid price of $10.2, and an ask price of $14.4. The implied volatility as of the 8th of June is 31.12.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Biogen |
Call options on Biogen give the investor right to buy Biogen Stock at a specified price within a specific period. The strike price represents the predetermined price at which a call buyer can buy Biogen Stock. Call options may be purchased for speculation or sold for income purposes, or simply combined for various spread or combination strategies. If Biogen's price is above the strike price at expiry, the profit is the current Biogen's stock price, minus the strike price and the premium.
Rule 16 of 2025-01-17 Option Contract
The options market is anticipating that Biogen Inc will have an average daily up or down price movement of about 1.95% per day over the life of the option. With Biogen trading at USD 225.43, that is roughly USD 4.38. If you think that the market is fully understating Biogen's daily price movement you should consider buying Biogen Inc options at that current volatility level of 31.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on Biogen
An 'Out of The Money' option on Biogen has a strike price that Biogen Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Biogen's 'Out of The Money' options include buying the options if you expect a big move in Biogen's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | 2025-01-17 CALL at $260.0 |
Expires On | 2025-01-17 |
Days Before Expriration | 223 |
Last Traded On | 2024-06-06 09:48:36 |
Contract Period | MONTHLY |
Open Interest | 190 |
Current Trading Volume | 0.0 |
Strike Price | 260.0 |
Last Traded At | 13.41 |
Current Price Spread | 10.2 | 14.4 |
Rule 16 Daily Up or Down | USD4.38 |
Biogen short CALL Option Greeks
Biogen's Option Greeks for the contract ending on 2025-01-17 at a strike price of 260.0 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Biogen's option greeks, its implied volatility helps estimate the risk of Biogen stock implied by the prices of the options on Biogen's stock.
Delta | 0.3707 | |
Gamma | 0.0069 | |
Theta | -0.0569 | |
Vega | 0.6656 | |
Rho | 0.4354 |
Biogen long CALL Option Payoff at expiration
Buying Biogen's call option is the simplest of option trades. A call option on Biogen Stock gives investors the right (but not the obligation) to purchase Biogen at the given strike price. Therefore Biogen's call intrinsic value or payoff at expiration depends on where the Biogen Stock price is relative to the call option strike price. The strike price of 260.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and negative (the trade is a loss). Above the strike, the payoff line is upward sloping as the option payoff rises in proportion with Biogen's price. Finally, at the break-even point of 272.3, the line crosses zero, and trading Biogen becomes profitable.
Profit |
Biogen Price At Expiration |
Biogen short CALL Option Payoff at expiration
By selling Biogen's call option, the investors signals his or her bearish sentiment. A short position in a call option written on Biogen will generally make money when the underlying price goes down. Therefore Biogen's call intrinsic value or payoff at expiration depends on where the Biogen Stock price is relative to the call option strike price. The strike price of 260.0 is the critical point that divides the payoff function into two parts. Below the strike, the payoff chart is constant and positive (the seller makes a profit). Above the strike, the payoff line is downward sloping as the option payoff drops in proportion to Biogen's price. Finally, at the break-even point of 272.3, the line crosses zero, and trading Biogen becomes disadvantageous with no downside limits.
Profit |
Biogen Price At Expiration |
Biogen Inc Available Call Options
Biogen's option chain is a display of a range of information that helps investors for ways to trade options on Biogen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biogen. It also shows strike prices and maturity days for a Biogen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-14 CALL at $125.0 | 0.9858 | 6.0E-4 | 0 | 2024-06-14 | 96.0 - 105.8 | 0.0 | In |
Call | 2024-06-14 CALL at $130.0 | 0.9835 | 7.0E-4 | 0 | 2024-06-14 | 91.0 - 100.9 | 0.0 | In |
Call | 2024-06-14 CALL at $135.0 | 0.9842 | 7.0E-4 | 0 | 2024-06-14 | 86.0 - 95.8 | 0.0 | In |
Call | 2024-06-14 CALL at $140.0 | 0.9913 | 5.0E-4 | 0 | 2024-06-14 | 81.0 - 90.4 | 0.0 | In |
Call | 2024-06-14 CALL at $145.0 | 0.9843 | 8.0E-4 | 0 | 2024-06-14 | 76.0 - 85.7 | 0.0 | In |
Call | 2024-06-14 CALL at $150.0 | 0.9856 | 8.0E-4 | 0 | 2024-06-14 | 71.0 - 80.6 | 0.0 | In |
Call | 2024-06-14 CALL at $155.0 | 0.9824 | 0.001 | 0 | 2024-06-14 | 66.0 - 75.7 | 0.0 | In |
Call | 2024-06-14 CALL at $160.0 | 0.9866 | 9.0E-4 | 0 | 2024-06-14 | 61.0 - 70.5 | 0.0 | In |
Call | 2024-06-14 CALL at $165.0 | 0.9828 | 0.0012 | 0 | 2024-06-14 | 56.0 - 65.6 | 0.0 | In |
Call | 2024-06-14 CALL at $170.0 | 0.9923 | 8.0E-4 | 0 | 2024-06-14 | 51.0 - 60.3 | 0.0 | In |
Call | 2024-06-14 CALL at $175.0 | 0.9876 | 0.0012 | 0 | 2024-06-14 | 46.0 - 55.4 | 0.0 | In |
Call | 2024-06-14 CALL at $180.0 | 0.8552 | 0.0042 | 0 | 2024-06-14 | 41.0 - 50.1 | 0.0 | In |
Call | 2024-06-14 CALL at $185.0 | 0.9983 | 4.0E-4 | 0 | 2024-06-14 | 36.0 - 45.2 | 0.0 | In |
Call | 2024-06-14 CALL at $190.0 | 0.8227 | 0.0055 | 0 | 2024-06-14 | 31.0 - 40.6 | 35.37 | In |
Call | 2024-06-14 CALL at $192.5 | 0.8215 | 0.006 | 0 | 2024-06-14 | 28.2 - 37.7 | 0.0 | In |
Call | 2024-06-14 CALL at $195.0 | 0.9715 | 0.0037 | 0 | 2024-06-14 | 26.0 - 35.6 | 0.0 | In |
Call | 2024-06-14 CALL at $197.5 | 0.8044 | 0.0071 | 0 | 2024-06-14 | 23.4 - 32.7 | 0.0 | In |
Call | 2024-06-14 CALL at $200.0 | 0.9211 | 0.0074 | 2 | 2024-06-14 | 21.0 - 30.2 | 26.34 | In |
Call | 2024-06-14 CALL at $202.5 | 0.7997 | 0.0089 | 0 | 2024-06-14 | 19.2 - 26.9 | 0.0 | In |
Call | 2024-06-14 CALL at $205.0 | 0.7812 | 0.0097 | 0 | 2024-06-14 | 16.2 - 24.7 | 0.0 | In |
Call | 2024-06-14 CALL at $207.5 | 0.9668 | 0.0071 | 0 | 2024-06-14 | 14.3 - 22.2 | 0.0 | In |
Call | 2024-06-14 CALL at $210.0 | 0.9543 | 0.0099 | 1 | 2024-06-14 | 12.1 - 19.5 | 7.25 | In |
Call | 2024-06-14 CALL at $212.5 | 0.8207 | 0.0171 | 0 | 2024-06-14 | 10.7 - 17.0 | 14.65 | In |
Call | 2024-06-14 CALL at $215.0 | 0.7976 | 0.0208 | 36 | 2024-06-14 | 7.0 - 12.2 | 21.14 | In |
Call | 2024-06-14 CALL at $217.5 | 0.7447 | 0.0244 | 2 | 2024-06-14 | 4.9 - 10.2 | 10.4 | In |
Call | 2024-06-14 CALL at $220.0 | 0.7412 | 0.0356 | 47 | 2024-06-14 | 3.1 - 7.9 | 7.07 | In |
Call | 2024-06-14 CALL at $222.5 | 0.6421 | 0.0408 | 0 | 2024-06-14 | 4.8 - 5.8 | 5.4 | In |
Call | 2024-06-14 CALL at $225.0 | 0.5348 | 0.0419 | 10 | 2024-06-14 | 3.8 - 4.4 | 4.5 | In |
Call | 2024-06-14 CALL at $227.5 | 0.4295 | 0.0418 | 52 | 2024-06-14 | 2.85 - 2.95 | 2.7 | Out |
Call | 2024-06-14 CALL at $230.0 | 0.3278 | 0.039 | 210 | 2024-06-14 | 1.9 - 2.25 | 1.95 | Out |
Call | 2024-06-14 CALL at $232.5 | 0.2593 | 0.032 | 22 | 2024-06-14 | 0.2 - 1.95 | 1.55 | Out |
Call | 2024-06-14 CALL at $235.0 | 0.186 | 0.0267 | 24 | 2024-06-14 | 0.6 - 1.1 | 1.0 | Out |
Call | 2024-06-14 CALL at $237.5 | 0.1296 | 0.021 | 41 | 2024-06-14 | 0.0 - 1.4 | 0.64 | Out |
Call | 2024-06-14 CALL at $240.0 | 0.0875 | 0.0157 | 40 | 2024-06-14 | 0.1 - 0.5 | 0.4 | Out |
Call | 2024-06-14 CALL at $245.0 | 0.0276 | 0.0066 | 407 | 2024-06-14 | 0.05 - 0.7 | 0.1 | Out |
Call | 2024-06-14 CALL at $250.0 | 0.0392 | 0.0066 | 24 | 2024-06-14 | 0.05 - 1.35 | 0.2 | Out |
Biogen Corporate Executives
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael CPA | Executive CFO | Profile |
Additional Information and Resources on Investing in Biogen Stock
When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.